MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis
- DOI
- 10.2147/bctt.s624272
- Published
- 2026-08
- Container
- Breast Cancer: Targets and Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2147/bctt.s624272,
title = {MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis},
author = {Fatih Atalah and Aydın Acarbay and Akgün Karakök and İsmail Nazlı and Onur Alkan and Okan Aydın and Oğuzhan Selvi and Mehmet Beşiroğlu and Mahmut Gümüş},
year = {2026},
journal = {Breast Cancer: Targets and Therapy},
doi = {10.2147/bctt.s624272},
url = {https://doi.org/10.2147/bctt.s624272}
}RIS
TY - JOUR TI - MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis AU - Fatih Atalah AU - Aydın Acarbay AU - Akgün Karakök AU - İsmail Nazlı AU - Onur Alkan AU - Okan Aydın AU - Oğuzhan Selvi AU - Mehmet Beşiroğlu AU - Mahmut Gümüş PY - 2026 JO - Breast Cancer: Targets and Therapy DO - 10.2147/bctt.s624272 UR - https://doi.org/10.2147/bctt.s624272 ER -
APA
Atalah, F., Acarbay, A., Karakök, A., Nazlı, İ., Alkan, O., Aydın, O., Selvi, O., Beşiroğlu, M., & Gümüş, M. (2026). MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis. Breast Cancer: Targets and Therapy. https://doi.org/10.2147/bctt.s624272
Source records
- crossref · retrieved 2026-09-25T01:43:45.000Z